Trevena

Manufacturing · Pennsylvania, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

955 Chesterbrook Blvd Ste 110, Chesterbr...

Phone Number

(610) 354-8840

Revenue

<$5 Million

Stock Symbol

TRVN

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Trevena

Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines for patients with CNS disorders. The Company has one approved product in the United States, OLINVYK® (oliceridine) injection, indicated in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. The Company's novel pipeline is based on Nobel Prize winning research and includes four differentiated investigational drug candidates: TRV250 for the acute treatment of migraine, TRV734 for maintenance treatment of opioid use disorder, TRV045 for diabetic neuropathic pain and epilepsy, and TRV027 for acute respiratory distress syndrome and abnormal blood clotting in COVID-19 patients.Explore more
Trevena's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: TRVNShow more

Trevena Org Chart

PhoneEmail
AB
United States flag for contact location.

Quality & Regulatory Affairs Vice President, ...

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Trevena

Compare insights from companies similar to Trevena, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Trevena

<$5M
11-50
Public
$110.8M
2008
AB
Angela BagleyQuality & Regulatory Affairs Vice President, Technical Operations
$311.5M
51-200
Public
-
2012
$41.7M
11-50
Public
$39.8M
2006
Laxminarayan Bhat, President & Chief Executive Officer at Reviva Pharmaceuticals
Laxminarayan BhatPresident & CEO
$13.5M
51-200
Private
$98.4M
2015
FV
Franky Van HerrewegheBusiness Development Manager, PhD
$11.1M
11-50
Private
<$5M
2005
Patty Ferrante, Chief Operating Officer at Melior Discovery
Patty FerranteChief Operating Officer
$7M
11-50
Private
<$5M
2017
N/A
Illustration of an envelope

Trevena Tech Stack

A closer look at the technologies used by Trevena

Top Manufacturing Companies

Frequently Asked Questions Regarding Trevena

What is Trevena's stock symbol?
Trevena's stock symbol is TRVN
What is Trevena's official website?
Trevena's official website is www.trevena.com
What is Trevena's Revenue?
Trevena's revenue is <$5 Million
What is Trevena's SIC code?
Trevena's SIC: 28,283
What is Trevena's NAICS code?
Trevena's NAICS: 32,325
How many employees does Trevena have?
Trevena has 11-50 employees
What industry does Trevena belong to?
Trevena is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Trevena competition?
Trevena top competitors include: Reviva Pharmaceuticals, Melior Discovery, Lipella Pharmaceuticals, Confo Therapeutics
What technology does Trevena use?
Some of the popular technologies that Trevena uses are: PHP, Microsoft SharePoint, Barracuda Networks, Microsoft Hyper-V
How do I contact Trevena?
Trevena contact info: Phone number: (610) 354-8840 Website: www.trevena.com
What does Trevena do?

Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines for patients with CNS disorders. The Company has one approved product in the United States, OLINVYK® (oliceridine) injection, indicated in adults for the management of acute pain severe enough to require an intravenous opioid analge... sic and for whom alternative treatments are inadequate. The Company's novel pipeline is based on Nobel Prize winning research and includes four differentiated investigational drug candidates: TRV250 for the acute treatment of migraine, TRV734 for maintenance treatment of opioid use disorder, TRV045 for diabetic neuropathic pain and epilepsy, and TRV027 for acute respiratory distress syndrome and abnormal blood clotting in COVID-19 patients.Read More

What are Trevena social media links?
Trevena Linkedin page Trevena Twitter page
Who invested in Trevena?
Trevena has 4 investors including R Bridge Group and CBC Group.
Is Trevena a public company?
Yes, Trevena is a public company and is traded under the symbol TRVN
See more information about Trevena

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.